{"id":"https://genegraph.clinicalgenome.org/r/98737cca-39c4-449e-bae5-1cf22d6d0c3dv1.0","type":"EvidenceStrengthAssertion","dc:description":"The *OTUD5* gene is located on chromosome X at Xp11.23 and encodes a lysine-48/lysine-63 linkage-specific deubiquitinase. *OTUD5* was first reported in relation to X-linked multiple congenital anomalies-neurodevelopmental syndrome in 2021 (Tripolszki et al.,PMID: 33131077). This disorder is characterized by characteristic craniofacial features, intellectual disability and global developmental delays, poor growth and with some individuals presenting with cardiac, skeletal, and genitourinary anomalies. The disorder has a very variable presentation. At least 11 unique variants (10 missense, 1 inframe deletion) have been reported in 12 probands in five publications (PMIDs: 33523931, 33131077, 35143101, 38037881, 33748114) and are included in this curation. This gene-disease relationship is supported by biochemical function studies, protein-protein interactions, and functional alterations in patient derived cells (PMIDs: 23827681, 28343629, 33523931). The mechanism of pathogenicity appears to be hypomorphic variants that are predominantly missense. In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date July 19, 2024 (SOP Version 10).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/98737cca-39c4-449e-bae5-1cf22d6d0c3d","GCISnapshot":"https://genegraph.clinicalgenome.org/r/1a19f1fb-a027-4580-92e5-936b8ca10692","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/1a19f1fb-a027-4580-92e5-936b8ca10692_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-07-19T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/1a19f1fb-a027-4580-92e5-936b8ca10692_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-09-26T15:29:36.277Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a19f1fb-a027-4580-92e5-936b8ca10692_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3616a544-8406-45c9-8b30-d02fb5d047a1","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3616a544-8406-45c9-8b30-d02fb5d047a1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33523931","allele":{"id":"https://genegraph.clinicalgenome.org/r/fad9b7a3-ad79-4b2b-99d3-a9a79982302f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001136157.2(OTUD5):c.1195C>T (p.Arg399Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA412908269"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/fc113e92-5c18-4fb5-828d-eb5d4f36c2ed","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc113e92-5c18-4fb5-828d-eb5d4f36c2ed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35143101","allele":{"id":"https://genegraph.clinicalgenome.org/r/b9047927-ec66-4a0b-8420-d4ee08145c15","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001136157.2(OTUD5):c.697G>A (p.Val233Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA412914062"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/455f4fea-93cd-4ad6-bb8a-b22a6f8c5193","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/455f4fea-93cd-4ad6-bb8a-b22a6f8c5193_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33748114","allele":{"id":"https://genegraph.clinicalgenome.org/r/fad9b7a3-ad79-4b2b-99d3-a9a79982302f"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9cccc47a-9f85-4a2a-afee-f247c51405e8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9cccc47a-9f85-4a2a-afee-f247c51405e8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The p.161-164del mutation specifically reduces OTUD5’s K48-ubiquitin chain cleavage activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9cccc47a-9f85-4a2a-afee-f247c51405e8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33523931","allele":{"id":"https://genegraph.clinicalgenome.org/r/fe744b21-fa63-4704-b9f6-0bd742ec93bf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001136157.2(OTUD5):c.482_490del (p.Val161_Gly163del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1132970281"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ee8c8279-2edc-44ea-97d0-5a75f5c93c58","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee8c8279-2edc-44ea-97d0-5a75f5c93c58_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38037881","allele":{"id":"https://genegraph.clinicalgenome.org/r/99979573-d5bd-4926-b125-356c71eb8ef4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001136157.2(OTUD5):c.1290T>A (p.Ser430Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA412907168"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e3431309-ec60-4b2b-84c2-79df28ed1119","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3431309-ec60-4b2b-84c2-79df28ed1119_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33748114","allele":{"id":"https://genegraph.clinicalgenome.org/r/89362968-f28e-4dca-9a3b-ccfca2e99de7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001136157.2(OTUD5):c.878A>T (p.Asn293Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA412913049"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/efea27ff-44bb-4175-895a-a15d24bac3e9","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/efea27ff-44bb-4175-895a-a15d24bac3e9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The Leu352Pro mutation specifically reduces OTUD5’s K48-ubiquitin chain cleavage activity.\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/efea27ff-44bb-4175-895a-a15d24bac3e9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33523931","allele":{"id":"https://genegraph.clinicalgenome.org/r/20bd3726-fbad-4a37-901d-3bc9e76b5856","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001136157.2(OTUD5):c.1040T>C (p.Leu347Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA412911730"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/88ec95b3-e2c9-4bab-a3e4-4fe6686a64e9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88ec95b3-e2c9-4bab-a3e4-4fe6686a64e9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33523931","allele":{"id":"https://genegraph.clinicalgenome.org/r/a3fec9d4-4597-43d2-a390-95c346304227","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001136157.2(OTUD5):c.1543C>T (p.Arg515Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA412906125"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ac099a94-f400-4825-8022-ec2714566be4","type":"EvidenceLine","dc:description":"This variant is affecting the 5′ splice site, leading to intron retention and reduced levels of OTUD5 mRNA and protein.\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac099a94-f400-4825-8022-ec2714566be4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant is affecting the 5′ splice site, leading to intron retention and reduced levels of OTUD5 mRNA and protein.\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/ac099a94-f400-4825-8022-ec2714566be4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33523931","allele":{"id":"https://genegraph.clinicalgenome.org/r/aa9e0c06-626e-407f-93c1-3556dcc430c8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001136157.2(OTUD5):c.1465G>A (p.Gly489Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA412906508"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f011de36-946d-47ce-967e-22e7503256d1","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f011de36-946d-47ce-967e-22e7503256d1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33131077","allele":{"id":"https://genegraph.clinicalgenome.org/r/1bcb1591-7f51-4fdb-8a9c-e923d79393d2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001136157.2(OTUD5):c.598G>A (p.Glu200Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA412915902"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1a19f1fb-a027-4580-92e5-936b8ca10692_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9bb0ca80-2441-4ea0-b17a-af7b328e7b2d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33131077","rdfs:label":"Tripolszki family","estimatedLodScore":2.41,"family":{"id":"https://genegraph.clinicalgenome.org/r/9bb0ca80-2441-4ea0-b17a-af7b328e7b2d","type":"Family","rdfs:label":"Tripolszki family","member":{"id":"https://genegraph.clinicalgenome.org/r/c99063eb-df68-44dd-9d52-1e2839c916a1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33131077","rdfs:label":"VI-6","allele":{"id":"https://genegraph.clinicalgenome.org/r/1bcb1591-7f51-4fdb-8a9c-e923d79393d2"},"phenotypeFreeText":"neurodevelopmental delay, ventricular septum defect, deep set eyes, hypertelorism, large forehead, flat nasal bridge, contracture flexed wrists and elbows, and paucity of spontaneous movements. A brain MRI showed delayed myelination, bilateral intraventricular hemorrhage, dysgenesis of corpus callosum, bilateral subependymal cysts, and colpocephaly.","phenotypes":["obo:HP_0000047","obo:HP_0000238","obo:HP_0001631","obo:HP_0001250","obo:HP_0004415","obo:HP_0000961","obo:HP_0002187","obo:HP_0002119","obo:HP_0002098","obo:HP_0001252","obo:HP_0001511"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f011de36-946d-47ce-967e-22e7503256d1_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Cardiovascular and renal malformations","phenotypeNegativeAlleleNegative":7,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0002187","obo:HP_0001252","obo:HP_0000047","obo:HP_0000238"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/c99063eb-df68-44dd-9d52-1e2839c916a1"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/06fe23b8-baec-48cd-ad5d-b8900d954e4f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06fe23b8-baec-48cd-ad5d-b8900d954e4f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The p.Arg274Trp mutation present in a conserved putative nuclear localization sequence caused a partial mis-localization of OTUD5 to the cytoplasm at steady-state expression in human embryonic stem cells.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/06fe23b8-baec-48cd-ad5d-b8900d954e4f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33523931","allele":{"id":"https://genegraph.clinicalgenome.org/r/1f30d45e-6f08-40fc-b6de-5b35234ae12f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001136157.2(OTUD5):c.820C>T (p.Arg274Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA412913414"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5e13aeec-08c5-4580-8d52-8cb6a7bc68ea","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e13aeec-08c5-4580-8d52-8cb6a7bc68ea_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The p.D256N mutation reduce OTUD5’s ability to hydrolyze Ub-AMC and reduce OTUD5 cleavage activity towards K63- and K48-chains.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5e13aeec-08c5-4580-8d52-8cb6a7bc68ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33523931","allele":{"id":"https://genegraph.clinicalgenome.org/r/821e7b60-2a1c-4de9-85cb-6c13ebea0e7a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001136157.2(OTUD5):c.766G>A (p.Asp256Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA412913684"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":7.4},{"id":"https://genegraph.clinicalgenome.org/r/1a19f1fb-a027-4580-92e5-936b8ca10692_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a19f1fb-a027-4580-92e5-936b8ca10692_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f9bba97a-5271-4f2f-a7e6-4fd065bba742","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80c76494-d1a2-417d-ad67-daf60d5e8bcb","type":"FunctionalAlteration","dc:description":"There was a notable defect in the neural differentiation capacity when comparing iPSCs of affected OTUD5-deficient patients to carrier mother. This was apparent by the loss of neural crest markers, including SOX10 and SNAIL2, and the aberrant expression of CNS markers, including increases in the forebrain marker FOXG1 and decreases in neural stem cell marker PAX6, as evidenced by immunoblotting and single-cell resolution by immunofluorescence.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33523931","rdfs:label":"Neural conversion"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1a19f1fb-a027-4580-92e5-936b8ca10692_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e25eef0b-ac46-4722-899b-db962d2d2b4a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/039fc0d1-0693-4b3f-b6ec-359abaebda86","type":"Finding","dc:description":"OTUD6B is shown to lead to an accumulation of ubiquitin-protein conjugates. Additionally it is associated with a similar disease to OTUD5 patients, where biallelic pathogenic variants in OTUD6B in 12 individuals with an intellectual disability syndrome were associated with seizures and dysmorphic features. Additional features include global developmental delay, microcephaly, absent speech, hypotonia, growth retardation with prenatal onset, feeding difficulties, structural brain abnormalities, congenital malformations including congenital heart disease, and musculoskeletal features. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28343629","rdfs:label":"Homologous gene","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2fe5ca1c-3aed-4b9d-a0be-198e4c684427","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a36b9909-5843-4ec4-84bb-ffe82e432171","type":"Finding","dc:description":"The linkage-specific ubiquitin chain cleavage of OTUD5 has an important physiological role during embryonic development. It affects multiple signaling pathways and cellular differentiation that leads to altered brain development (PMID: 33523931). ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23827681","rdfs:label":"Deubiquitylation activity","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/efb7ff92-781f-4379-af8c-d3577b9f1039","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd49d501-c09e-428e-989d-c96187bf1dc6","type":"Finding","dc:description":"The interacting genes ARID1A, ARID1B, HDAC2 and UBR5 are involved in diseases with similar phenotypes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33523931","rdfs:label":"Tandem Ubiquitin-Binding Entity based mass spectrometry","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Moderate","sequence":9049,"specifiedBy":"GeneValidityCriteria10","strengthScore":9.9,"subject":{"id":"https://genegraph.clinicalgenome.org/r/gpCn1-aKqA8","type":"GeneValidityProposition","disease":"obo:MONDO_0025351","gene":"hgnc:25402","modeOfInheritance":"obo:HP_0001417"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_1a19f1fb-a027-4580-92e5-936b8ca10692-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}